Atlas Trials

Scioto Biosciences, Inc.

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Scioto Biosciences, Inc.

RecordFirmDate
28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder (NCT04944901)Scioto Biosciences, Inc.2021-08-02

Track Scioto Biosciences, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.